American Portfolios Advisors Omeros Corp Transaction History

American Portfolios Advisors

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Mar 22, 2023	BUY	$13.4 - $16.3 $26,800 - $32,600	2,000 New	2,000 $27.6 Million
Q3 2019 Mar 24, 2023	SELL	$14.55 - $20.56 $18,187 - $25,700	-1,250 Closed	0 $0
Q2 2019 Mar 24, 2023	BUY	$15.0 - $19.62 $18,750 - $24,525	1,250 New	1,250 $19.6 Million
Q1 2019 Mar 24, 2023	SELL	$11.65 - $17.72 $9,320 - $14,176	-800 Reduced 35.56%	1,450 $25.2 Million
Q4 2018 Mar 24, 2023	BUY	$10.72 - $16.73 $2,144 - $3,346	200 Added 9.76%	2,250 $25.1 Million
Q3 2018 Mar 24, 2023	BUY	$17.73 - $26.69 $36,346 - $54,714	2,050 New	2,050 $50 Million
Q2 2018 Mar 24, 2023	BUY	$10.79 - $24.44 $22,119 - $50,102	2,050 New	2,050 $37.2 Million

139

25.9M

718K

598K

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $576M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.